Action Advances Fight Against COVID-19, Follows Comprehensive Evaluation of Available Safety, Effectiveness and Manufacturing Quality Information by FDA Career Scientists, Input from External Experts Today, the U.S. Food and Drug Administration issued an emergency use...
The phase 3a STEP 1 trial that investigated the use of semaglutide (Novo Nordisk), a glucagon-like peptide-1 (GLP-1) agonist, for weight loss is aptly named, some say. “In sum, we have a long way to go to control the obesity epidemic…but on the face of it,...
More than half of participants taking the highest dose achieved normal A1C levels, a key secondary endpoint in first phase 3 trial of SURPASS program Participants in this monotherapy study had relatively recently diagnosed diabetes, with a mean duration of 4.7 years...
ABSTRACT Issue: States are facing large revenue shortfalls and budget deficits from the COVID-19 crisis. To close deficits, they will need to raise taxes, cut spending to critical public programs like Medicaid, or both. Goals: Examine the long-term benefits of...
Patients with lower back pain prescribed skeletal muscle relaxants in addition to NSAIDs report the same outcomes as placebo plus NSAIDs, new research shows. “Combining a skeletal muscle relaxant with an NSAID does not confer any additional benefit,”...
“Our study in nonelderly adults with depression did not identify a single predominant cause of death. However, this may be a result of both the relatively small number of deaths in our study as well as of the well-recognized concerns regarding the accuracy of...
Recent Comments